Aequorea Vision Medical Inc.

Physicians

The AVM™ SureScreen System provides an accurate, easy-to-use visual test for cervical cancer screening. The light-based exam allows instant and accurate identification of HPV damaged cells and lesions in patients, the precursors to cervical cancer. Aequorea’s breakthrough technology allows health care professionals to SEE AND TREAT, meaning that they can visually identify and instantaneously treat HPV damaged cells and lesions in patients without a Pap test. With AVM’s technology, health care professionals will be able to monitor and treat infection (if necessary) in order to prevent the development of cervical cancer.

The number of women affected by cervical cancer is growing worldwide. Cervical cancer is currently the second most common cancer in women, and yet it is a preventable disease. Regular Pap tests and cervical exams have successfully decreased, but not eliminated, cervical cancer rates in industrialized countries.

AVM™ SureScreen System technology provides an effective screening test that is:

98% Accurate, with immediate and visual results
Cost Effective
Time Effective
Easy-to-use

The advantages of using AVM™ SureScreen System over other cervical cancer screening tests are numerous.

The AVM™ SureScreen System was developed by physicians and scientists abroad, who were in dire need for an effective cervical cancer screening test. This system, in a clinical study (with AVM’s very first prototype) with the National Autonomous University of Mexico (UNAM), outperformed the gold standards of the Pap test and colposcopy. The AVM™ System achieved a 98% sensitivity and 88% specificity.

The AVM™ SureScreen System has products for every clinical setting, from an "AVM™ Inside" colposcope, to portable and disposable AVM™ testing devices.

The AVM™ Inside Colposcope allows the physician to perform both the AVM™ SureScreen System exam and routine colposcopy. Detection of tissue changes, which require years of training and experience in colposcopy, are easily seen with the AVM™ SureScreen System.
The AVM™ SureScreen Portable System can be used as, either sterilizable and re-usable or disposable, single-use models. The patented light technology can be equipped with a battery power source, allowing for use in even the most remote areas.

For more information about AVM™ SureScreen devices for clinical applications, please CONTACT US.

Enter your email address below

Did you know?

Every 2 minutes a woman dies of cervical cancer somewhere in the world.

Approximately 20 million Americans are infected with Human Papillomavirus (HPV).

Cervical Cancer is the second most common cancer in women.

Approximately 5.5 million people will contract HPV each year.

There are more than 40 HPV types that can infect the genital areas of males and females.

Each year, about 12,000 women get cervical cancer in the U.S.

Papillomatosis becomes a herd problem when a large group of young, susceptible cattle become infected.

A horse that has even one lesion, is liable to the disease for life.

Sarcoids multiply over the summer and grow over the winter.

You should keep cattle with warts away from all horses to prevent Sarcoid development.

The simplest method of prevention is to separate infected animals from healthy animals.

It is important to minimize the use of equipment, feeders, waters, etc. that come into contact with healthy and unhealthy animals.

Sarcoids can develop in all equid species including the Horse, Donkey, Mule, Zebra, and Przewalksi Horse.